Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

GYREGYRE THERAPEUTICS, INC.

Nasdaq · CIK 0001124105
Filer categoryAccelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts515

Identity from submissions API

NameGYRE THERAPEUTICS, INC.
CIK0001124105
TickersGYRE
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN562020050
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(858) 284-0115
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • CATALYST BIOSCIENCES, INC. (2015-06-23T04:00:00.000Z → 2023-10-27T04:00:00.000Z)
  • TARGACEPT INC (2002-12-16T05:00:00.000Z → 2015-08-19T04:00:00.000Z)
Business address
12730 HIGH BLUFF DRIVE
SUITE 250
SAN DIEGO
CA
92130
CA
Mailing address
12730 HIGH BLUFF DRIVE
SUITE 250
SAN DIEGO
CA
92130
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1604 filing rows loaded from submissions recent; extra archives: CIK0001124105-submissions-001.json (603 filings, 2002-12-16 to 2013-09-29).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-06 10-Q 10-Q 0001193125-26-450334 000-51173 261528903 34 20568803 1 1
2026-11-05 8-K 8-K 2.02,7.01,9.01 0001193125-26-449985 000-51173 261527899 34 13068435 1 1
2026-10-22 8-K 8-K 5.02,9.01 0001140361-26-040506 000-51173 261478825 34 416407 1 1
2026-09-01 8-K 8-K 7.01,9.01 0001140361-26-035189 000-51173 261348634 34 4787022 1 1
2026-08-27 S-8 S-8 0001140361-26-034882 333-298646 261341927 33 190817 1 1
2026-08-26 8-K 8-K 7.01,9.01 0001140361-26-034401 000-51173 261317756 34 7822104 1 1
2026-08-07 10-Q 10-Q 0001193125-26-340448 000-51173 261255231 34 19910377 1 1
2026-08-07 8-K 8-K 2.02,9.01 0001193125-26-339223 000-51173 261251465 34 722297 1 1
2026-08-04 4 FORM 4 0001140361-26-031326 5525
2026-08-04 4 FORM 4 0001140361-26-031324 5528
2026-08-04 3 FORM 3 0001140361-26-031322 11866
2026-08-04 3 FORM 3 0001140361-26-031320 11620
2026-08-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002523 333-296957 261235227 33 1957
2026-07-16 8-K 8-K 5.02,7.01,9.01 0001140361-26-028716 000-51173 261180765 34 175567 1 1
2026-07-15 8-K/A 8-K/A 2.02,9.01 0001140361-26-028564 000-51173 261178033 34 2666982 1 1
2026-07-13 S-3/A S-3/A 0001140361-26-028333 333-296957 261171903 33 686723 1 1
2026-06-30 4 FORM 4 0001140361-26-027008 5536
2026-06-30 4 FORM 4 0001140361-26-027007 5561
2026-06-30 4 FORM 4 0001140361-26-027006 5509
2026-06-30 4 FORM 4 0001140361-26-027005 5549
2026-06-30 4 FORM 4 0001140361-26-027004 5543
2026-06-30 4 FORM 4 0001140361-26-027003 5564
2026-06-23 S-3 S-3 0001140361-26-025999 333-296957 261108511 33 757247 1 1
2026-06-22 4 FORM 4 0001140361-26-025950 18046
2026-06-16 8-K 8-K 5.07 0001140361-26-025324 000-51173 261092841 34 172924 1 1
2026-06-15 4 FORM 4 0001140361-26-025208 8580
2026-06-11 4 FORM 4 0001140361-26-024929 13789
2026-06-10 4 FORM 4 0001140361-26-024785 5671
2026-06-10 4 FORM 4 0001140361-26-024784 5675
2026-06-10 S-8 S-8 0001140361-26-024702 333-296657 261077882 33 290805 1 1
2026-06-08 4 FORM 4 0001140361-26-024449 13790
2026-06-02 8-K 8-K 7.01,9.01 0001140361-26-023625 000-51173 261053500 34 8942912 1 1
2026-05-27 4 FORM 4 0001140361-26-022980 13317
2026-05-22 4 FORM 4 0001140361-26-022642 13791
2026-05-20 4 xslF345X06/form4.xml 0001140361-26-022303 14063
2026-05-20 4 FORM 4 0001140361-26-022235 13787
2026-05-18 4 FORM 4 0001140361-26-021889 13792
2026-05-14 8-K 8-K 7.01,9.01 0001140361-26-021360 000-51173 26980591 34 4615294 1 1
2026-05-12 8-K 8-K 7.01,9.01 0001140361-26-020845 000-51173 26969688 34 185200 1 1
2026-05-11 144 xsl144X01/primary_doc.xml 0001985496-26-000001 000-51173 26960844 33 4484
2026-05-08 10-Q 10-Q 0001193125-26-214676 000-51173 26958574 34 13486198 1 1
2026-05-07 4 FORM 4 0001140361-26-019658 6954
2026-05-07 3 FORM 3 0001140361-26-019652 12563
2026-05-07 3 FORM 3 0001140361-26-019651 15663
2026-05-07 3 FORM 3 0001140361-26-019650 13564
2026-05-07 3 FORM 3 0001140361-26-019649 19231
2026-05-07 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001140361-26-019395 005-82442 26950578 34 12910
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-209789 000-51173 26950359 34 559875 1 1
2026-05-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001140361-26-019388 005-82442 26950506 34 19838
2026-05-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001140361-26-019380 005-82442 26950410 34 21482
2026-05-06 4 FORM 4 0001140361-26-019378 11972
2026-05-06 4 FORM 4 0001140361-26-019376 25700
2026-05-04 DEFA14A DEFA14A 0001140361-26-018717 000-51173 26934898 34 342971
2026-05-04 8-K 8-K 2.01,3.02,3.03,5.02,5.03,7.01,9.01 0001140361-26-018716 000-51173 26934897 34 580253 1 1
2026-04-27 ARS ARS 0001140361-26-017132 000-51173 26901499 34 1914218
2026-04-27 DEFA14A DEFA14A 0001140361-26-017130 000-51173 26901485 34 1314468
2026-04-27 DEF 14A DEF 14A 0001140361-26-017124 000-51173 26901468 34 5801942 1 1
2026-04-17 8-K/A 8-K/A 1.01,9.01 0001140361-26-015307 000-51173 26869574 34 173632 1 1
2026-04-16 PRE 14A PRE 14A 0001140361-26-015133 000-51173 26867717 34 5794130 1 1
2026-03-23 8-K 8-K 8.01 0001140361-26-010654 000-51173 26779923 34 157793 1 1
2026-03-13 10-K 10-K 0001193125-26-106251 000-51173 26752940 34 23656114 1 1
2026-03-12 8-K 8-K 7.01 0001140361-26-009115 000-51173 26745582 34 171901 1 1
2026-03-12 8-K 8-K 2.02,9.01 0001193125-26-102700 000-51173 26745157 34 690854 1 1
2026-03-02 8-K 8-K 1.01,3.02,5.02,5.03,7.01,9.01 0001140361-26-007249 000-51173 26703894 34 7046292 1 1
2026-01-09 4 FORM 4 0001140361-26-000832 5464
2026-01-09 4 FORM 4 0001140361-26-000831 5487
2026-01-05 8-K FORM 8-K 7.01,9.01 0001140361-26-000253 000-51173 26503880 34 175373 1 1
2025-11-13 144 xsl144X01/primary_doc.xml 0001985496-25-000003 000-51173 251480614 33 5131
2025-11-07 10-Q 10-Q 0001193125-25-272383 000-51173 251462862 34 16489586 1 1
2025-11-07 8-K 8-K 2.02,9.01 0001193125-25-270524 000-51173 251460240 34 671486 1 1
2025-09-10 8-K 8-K 8.01,9.01 0001140361-25-034506 000-51173 251304778 34 4731371 1 1
2025-08-26 4 FORM 4 0001140361-25-032719 5369
2025-08-26 3 FORM 3 0001140361-25-032710 11875
2025-08-22 8-K 8-K 5.02,7.01,9.01 0001140361-25-032295 000-51173 251242183 34 185374 1 1
2025-08-11 10-Q 10-Q 0000950170-25-106644 000-51173 251202918 34 15575565 1 1
2025-08-11 8-K 8-K 2.02,5.02,7.01,9.01 0000950170-25-106525 000-51173 251201889 34 681520 1 1
2025-08-07 4 FORM 4 0001140361-25-029693 5412
2025-06-06 4 FORM 4 0001140361-25-021793 5377
2025-06-06 4 FORM 4 0001140361-25-021792 5375
2025-06-06 4 FORM 4 0001140361-25-021791 5367
2025-06-06 4 FORM 4 0001140361-25-021790 5354
2025-06-06 4 FORM 4 0001140361-25-021789 5369
2025-06-06 8-K 8-K 5.07 0001140361-25-021612 000-51173 251028591 34 169490 1 1
2025-05-29 4 FORM 4 0001140361-25-020754 7229
2025-05-28 4 FORM 4 0001140361-25-020669 5410
2025-05-27 4 FORM 4 0001140361-25-020474 7229
2025-05-23 8-K 8-K 1.01,9.01 0001140361-25-020353 000-51173 25983092 34 741470 1 1
2025-05-23 424B5 424B5 0001140361-25-020349 333-283237 25983005 33 701278
2025-05-22 424B5 424B5 0001140361-25-020208 333-283237 25978356 33 702164
2025-05-22 8-K 8-K 7.01,8.01,9.01 0001140361-25-020157 000-51173 25976969 34 5949460 1 1
2025-05-22 4 FORM 4 0001140361-25-020156 7231
2025-05-20 4 FORM 4 0001140361-25-019893 7230
2025-05-16 4 FORM 4 0001140361-25-019468 7206
2025-05-14 4 FORM 4 0001140361-25-019053 6596
2025-05-14 4 FORM 4 0001140361-25-018927 7230
2025-05-09 10-Q 10-Q 0000950170-25-068089 000-51173 25930945 34 12877809 1 1
2025-05-09 8-K 8-K 2.02,9.01 0000950170-25-067452 000-51173 25928081 34 553311 1 1
2025-04-28 8-K 8-K 7.01,9.01 0001140361-25-015880 000-51173 25875922 34 5460735 1 1
2025-04-25 4 FORM 4 0001140361-25-015712 13354
2025-04-22 ARS ARS 0001140361-25-014874 000-51173 25856818 34 1896307
2025-04-21 DEFA14A DEFA14A 0001140361-25-014780 000-51173 25854461 34 969992
2025-04-21 DEF 14A DEF 14A 0001140361-25-014779 000-51173 25854452 34 5657238 1 1
2025-04-18 4 FORM 4 0001140361-25-014601 6564
2025-03-25 4 FORM 4 0001140361-25-010234 5233
2025-03-21 4 FORM 4 0001140361-25-009877 7236
2025-03-20 S-8 S-8 0001140361-25-009676 333-285954 25756371 33 114113
2025-03-19 4 FORM 4 0001140361-25-009424 7236
2025-03-17 10-K 10-K 0000950170-25-040279 000-51173 25744620 34 23690009 1 1
2025-03-17 8-K 8-K 2.02,9.01 0000950170-25-040232 000-51173 25744374 34 700006 1 1
2025-03-17 4 FORM 4 0001140361-25-009017 7235
2025-03-13 4 FORM 4 0001140361-25-008623 7237
2025-03-11 4 FORM 4 0001140361-25-008167 5417
2025-03-11 4 FORM 4 0001140361-25-008091 11219
2025-03-07 4 FORM 4 0001140361-25-007602 7235
2025-03-05 4 FORM 4 0001140361-25-007173 7236
2025-03-03 4 FORM 4 0001140361-25-006738 7236
2025-02-27 4 FORM 4 0001140361-25-006273 7236
2025-02-25 4 FORM 4 0001140361-25-005842 11218
2025-02-21 4 FORM 4 0001140361-25-005420 7234
2025-02-19 4 FORM 4 0001140361-25-005113 7236
2025-02-18 8-K 8-K 2.02,7.01,9.01 0001140361-25-004957 000-51173 25632389 34 711571 1 1
2025-02-14 4 FORM 4 0001140361-25-004744 7237
2025-02-12 4 FORM 4 0001140361-25-004126 7235
2025-02-11 4 FORM 4 0001140361-25-003831 7237
2025-02-06 4 FORM 4 0001140361-25-003426 9228
2025-02-04 4 FORM 4 0001140361-25-002995 7236
2025-01-31 4 FORM 4 0001140361-25-002702 7236
2025-01-29 4 FORM 4 0001140361-25-002340 7236
2025-01-27 4 FORM 4 0001140361-25-002062 7236
2025-01-24 4 FORM 4 0001140361-25-001891 7236
2025-01-21 4 FORM 4 0001140361-25-001526 7236
2025-01-16 4 FORM 4 0001140361-25-001283 7236
2025-01-14 4 FORM 4 0001140361-25-001059 7233
2025-01-10 4/A FORM 4/A 0001140361-25-000827 4952
2025-01-08 4 FORM 4 0001140361-25-000610 7235
2025-01-07 4 FORM 4 0001140361-25-000426 5358
2025-01-07 3 FORM 3 0001140361-25-000425 10857
2025-01-06 4 FORM 4 0001140361-25-000339 9227
2025-01-06 8-K 8-K 5.02,7.01,9.01 0001140361-25-000292 000-51173 25509020 34 241988 1 1
2025-01-02 4 FORM 4 0001140361-25-000074 7234
2024-12-30 4 FORM 4 0001140361-24-050588 9229
2024-12-26 4 FORM 4 0001140361-24-050413 9229
2024-12-23 4 FORM 4 0001140361-24-050250 7236
2024-12-19 4 FORM 4 0001140361-24-049939 11222
2024-11-27 8-K 8-K 1.01,9.01 0001140361-24-047980 000-51173 241511555 34 556771 1 1
2024-11-27 424B5 424B5 0001140361-24-047979 333-283237 241511501 33 603340
2024-11-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-11-22 16:15:00 9999999995-24-003565 333-283237 241491753 33 1940
2024-11-20 CORRESP filename1.htm 0001140361-24-047382 46156
2024-11-20 UPLOAD filename1.pdf 0000000000-24-012864 333-283237 40228
2024-11-14 S-3 S-3 0001140361-24-046940 333-283237 241463517 33 1150072
2024-11-13 10-Q 10-Q 0000950170-24-126306 000-51173 241454062 34 11965193 1 1
2024-11-13 8-K 8-K 2.02,9.01 0000950170-24-125869 000-51173 241450812 34 538094 1 1
2024-09-06 SC 13D SC 13D 0001140361-24-040318 005-82442 241283026 34 90874
2024-09-06 SC 13D SC 13D 0001140361-24-040313 005-82442 241282994 34 89078
2024-08-16 4 FORM 4 0001140361-24-037717 5377
2024-08-16 4 FORM 4 0001140361-24-037714 5364
2024-08-16 4 FORM 4 0001140361-24-037713 5385
2024-08-16 4 FORM 4 0001140361-24-037712 5379
2024-08-16 4 FORM 4 0001140361-24-037709 5455
2024-08-16 4 FORM 4 0001140361-24-037708 5387
2024-08-16 4 FORM 4 0001140361-24-037707 5380
2024-08-16 4 FORM 4 0001140361-24-037706 5443
2024-08-16 4 FORM 4 0001140361-24-037705 5519
2024-08-13 10-Q 10-Q 0000950170-24-096159 000-51173 241201354 34 11495060 1 1
2024-08-13 8-K 8-K 2.02,9.01 0000950170-24-095687 000-51173 241198462 34 539316 1 1
2024-08-08 4 FORM 4 0001140361-24-036417 5318
2024-08-08 3 FORM 3 0001140361-24-036410 10639
2024-08-08 8-K 8-K 5.02,7.01,8.01,9.01 0001140361-24-036404 000-51173 241188526 34 246963 1 1
2024-07-18 144 xsl144X01/primary_doc.xml 0001950047-24-005523 000-51173 241125124 33 10754
2024-07-17 144 xsl144X01/primary_doc.xml 0001950047-24-005496 000-51173 241122548 33 10007
2024-07-16 144 xsl144X01/primary_doc.xml 0001950047-24-005430 000-51173 241119694 33 9256
2024-07-15 144 xsl144X01/primary_doc.xml 0001950047-24-005428 000-51173 241118055 33 8509
2024-07-12 RW RW 0001140361-24-033067 333-279822 241114985 NE 64281
2024-07-12 RW RW 0001140361-24-033066 333-279820 241114978 NE 64453
2024-07-05 8-K 8-K 3.01,5.02 0001140361-24-032511 000-51173 241102954 34 167720 1 1
2024-07-03 144 xsl144X01/primary_doc.xml 0001950047-24-005238 000-51173 241099239 33 7852
2024-07-02 144 xsl144X01/primary_doc.xml 0001950047-24-005217 000-51173 241096909 33 7108
2024-07-01 4 FORM 4 0001140361-24-032024 9876
2024-07-01 144 xsl144X01/primary_doc.xml 0001950047-24-005185 000-51173 241092149 33 6359
2024-06-28 144 xsl144X01/primary_doc.xml 0001950047-24-005100 000-51173 241086935 33 6367
2024-06-17 8-K 8-K 5.03,5.07,9.01 0001140361-24-030348 000-51173 241048702 34 201789 1 1
2024-05-30 S-3 S-3 0001140361-24-028107 333-279822 241005208 33 1228040
2024-05-30 8-K 8-K 7.01,8.01,9.01 0001140361-24-028106 000-51173 241005171 34 190834 1 1
2024-05-30 S-3 S-3 0001140361-24-028104 333-279820 241005106 33 691135
2024-05-13 10-Q 10-Q 0000950170-24-058642 000-51173 24939057 34 9957494 1 1
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056893 000-51173 24930449 34 448643 1 1
2024-05-08 8-K 8-K 7.01,8.01,9.01 0001140361-24-024799 000-51173 24924299 34 202045 1 1
2024-05-02 4 FORM 4 0001140361-24-024125 13091
2024-05-01 144 xsl144X01/primary_doc.xml 0001950047-24-003294 000-51173 24903822 33 6361
2024-04-29 ARS ARS 0001140361-24-022725 000-51173 24886870 34 1968924
2024-04-29 DEFA14A DEFA14A 0001140361-24-022723 000-51173 24886866 34 1318230
2024-04-29 DEF 14A DEF 14A 0001140361-24-022721 000-51173 24886801 34 2860843
2024-04-19 PRE 14A PRE 14A 0001140361-24-020769 000-51173 24857777 34 2745368
2024-04-09 144 xsl144X01/primary_doc.xml 0001950047-24-003018 000-51173 24833118 33 10933
2024-04-08 144 xsl144X01/primary_doc.xml 0001950047-24-002998 000-51173 24830669 33 10185
2024-04-05 144 xsl144X01/primary_doc.xml 0001950047-24-002968 000-51173 24827617 33 9437
2024-04-04 144 xsl144X01/primary_doc.xml 0001950047-24-002957 000-51173 24824103 33 8689
2024-04-03 144 xsl144X01/primary_doc.xml 0001950047-24-002931 000-51173 24819668 33 7941
2024-04-03 4 FORM 4 0001140361-24-017566 9822
2024-04-02 144 xsl144X01/primary_doc.xml 0001950047-24-002904 000-51173 24815876 33 6447
2024-04-01 144 xsl144X01/primary_doc.xml 0001950047-24-002847 000-51173 24811611 33 5609
2024-03-28 S-8 S-8 0001140361-24-015774 333-278291 24793097 33 78663
2024-03-27 10-K 10-K 0000950170-24-037242 000-51173 24791282 34 18521271 1 1
2024-03-26 8-K 8-K 3.01 0001140361-24-015318 000-51173 24784519 34 162721 1 1
2024-03-26 8-K 8-K 2.02,9.01 0000950170-24-036135 000-51173 24780805 34 462587 1 1
2024-03-21 4 FORM 4 0001140361-24-014680 5309
2024-03-21 3 FORM 3 0001140361-24-014678 11716
2024-03-21 8-K 8-K 5.02,7.01,9.01 0001140361-24-014493 000-51173 24769412 34 191511 1 1
2024-03-19 4 FORM 4 0001140361-24-014164 9821
2024-03-15 144 xsl144X01/primary_doc.xml 0001950047-24-002421 000-51173 24756131 33 4857
2024-02-14 8-K 8-K 2.02,7.01,9.01 0001140361-24-008051 000-51173 24640564 34 1043615 1 1
2024-02-14 SC 13G/A catalyst13ga2.htm 0000935836-24-000173 005-82442 24635432 34 30500
2024-01-24 SC 13D/A SC 13D/A 0001140361-24-003688 005-82442 24557513 34 76944
2024-01-19 8-K/A 8-K/A 3.01,5.02,9.01 0001140361-24-002903 000-51173 24545596 34 303907 1 1
2024-01-12 8-K/A 8-K/A 2.01,9.01 0001140361-24-002118 000-51173 24532043 34 2167233 1 1
2023-12-15 8-K 8-K 5.02 0001140361-23-057889 000-51173 231490653 34 166700 1 1
2023-12-06 8-K 8-K 7.01,9.01 0001140361-23-056503 000-51173 231469572 34 220167 1 1
2023-11-29 RW RW 0001140361-23-055209 333-275466 231452121 NE 24213
2023-11-27 SC 13D/A SC 13D/A 0001140361-23-054720 005-82442 231440797 34 74665
2023-11-22 4 xslF345X05/form4.xml 0001140361-23-054522 10847
2023-11-22 4 xslF345X05/form4.xml 0001140361-23-054520 5840
2023-11-22 4 xslF345X05/form4.xml 0001140361-23-054518 5877
2023-11-22 4 xslF345X05/form4.xml 0001140361-23-054516 5804
2023-11-22 4 xslF345X05/form4.xml 0001140361-23-054514 7944
2023-11-22 4 xslF345X05/form4.xml 0001140361-23-054511 5889
2023-11-22 3/A xslF345X02/form3.xml 0001140361-23-054506 5396
2023-11-14 8-K 8-K 7.01,9.01 0001140361-23-053086 000-51173 231401526 34 965488 1 1
2023-11-13 D xslFormDX01/primary_doc.xml 06b 0001140361-23-052961 021-497103 231400025 33 12723
2023-11-13 8-K 8-K 7.01,9.01 0001140361-23-052715 000-51173 231395010 34 208794 1 1
2023-11-13 S-3 S-3 0001140361-23-052634 333-275466 231394404 33 465922
2023-11-06 8-K FORM 8-K 7.01,9.01 0001140361-23-051485 000-51173 231377994 34 204338 1 1
2023-11-02 8-K FORM 8-K 4.01,5.02,9.01 0001140361-23-051195 000-51173 231373396 34 330134 1 1
2023-11-01 424B3 424B3 0001140361-23-050892 333-273395 231369217 33 364865
2023-11-01 SC 13D/A SC 13D/A 0001140361-23-050866 005-82442 231369037 34 65700
2023-11-01 4 xslF345X05/form4.xml 0001140361-23-050620 5179
2023-11-01 4 xslF345X05/form4.xml 0001140361-23-050619 7268
2023-11-01 4 xslF345X05/form4.xml 0001140361-23-050618 5163
2023-11-01 4 xslF345X05/form4.xml 0001140361-23-050617 5007
2023-11-01 4 xslF345X05/form4.xml 0001140361-23-050616 7120
2023-11-01 4 xslF345X05/form4.xml 0001140361-23-050615 5151
2023-11-01 4 xslF345X05/form4.xml 0001140361-23-050614 5180
2023-11-01 3 xslF345X02/form3.xml 0001140361-23-050612 11054
2023-11-01 3 xslF345X02/form3.xml 0001140361-23-050611 11562
2023-11-01 3 xslF345X02/form3.xml 0001140361-23-050610 12203
2023-11-01 3 xslF345X02/form3.xml 0001140361-23-050609 10688
2023-11-01 3 xslF345X02/form3.xml 0001140361-23-050613 11457
2023-11-01 3 xslF345X02/form3.xml 0001140361-23-050608 10462
2023-11-01 3 xslF345X02/form3.xml 0001140361-23-050607 10802
2023-10-31 4 xslF345X05/form4.xml 0001140361-23-050569 10253
2023-10-31 SC 13D/A SC 13D/A 0001140361-23-050328 005-82442 231361932 34 109089
2023-10-31 S-8 FORM S-8 0001140361-23-050314 333-275222 231361721 33 523192
2023-10-30 8-K FORM 8-K 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,7.01,9.01 0001140361-23-050292 000-51173 231361476 34 1698308 1 1
2023-10-27 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-10-27 09:00:00 9999999995-23-003116 333-273395 231357063 33 1771
2023-10-27 3 xslF345X02/form3.xml 0001140361-23-050021 16455
2023-10-27 4 xslF345X05/form4.xml 0001140361-23-050019 7590
2023-10-27 8-K 8-K 7.01,9.01 0001140361-23-050007 000-51173 231356478 34 192830 1 1
2023-10-27 424B3 FORM 424B3 0001140361-23-049997 333-273395 231356309 33 350145
2023-10-26 10-Q 10-Q 0000950170-23-055695 000-51173 231351213 34 7645356 1 1
2023-10-24 CORRESP filename1.htm 0001140361-23-049323 36102
2023-10-24 S-3/A FORM S-3/A 0001140361-23-049322 333-273395 231342797 33 577935
2023-10-23 8-K 8-K 8.01 0001140361-23-049083 000-51173 231338085 34 165959 1 1
2023-10-13 CORRESP filename1.htm 0001140361-23-048201 107916
2023-10-13 S-3/A S-3/A 0001140361-23-048195 333-273395 231325307 33 551292
2023-09-01 4 xslF345X05/form4.xml 0001140361-23-042369 5356
2023-09-01 4 xslF345X05/form4.xml 0001140361-23-042367 8461
2023-09-01 4 xslF345X05/form4.xml 0001140361-23-042368 5293
2023-09-01 4 xslF345X05/form4.xml 0001140361-23-042366 9412
2023-09-01 4 xslF345X05/form4.xml 0001140361-23-042365 6924
2023-08-31 8-K 8-K 1.01,3.03,5.03,5.07,8.01,9.01 0001140361-23-042067 000-51173 231229253 34 279390 1 1
2023-08-14 10-Q 10-Q 0000950170-23-042218 000-51173 231168108 34 8461563 1 1
2023-08-14 8-K 8-K 2.02,9.01 0001140361-23-039357 000-51173 231165956 34 879276 1 1
2023-08-03 UPLOAD filename1.pdf 0000000000-23-008337 44923
2023-07-24 S-3 S-3 0001140361-23-035866 333-273395 231105502 33 650805
2023-07-20 UPLOAD filename1.pdf 0000000000-23-007720 39902
2023-07-20 DEFM14A FORM DEFM14A 0001140361-23-035323 000-51173 231098246 34 16093841
2023-07-12 CORRESP filename1.htm 0001140361-23-034225 310593
2023-07-12 PRER14A PRER14A 0001140361-23-034222 000-51173 231084543 34 16061854
2023-07-10 UPLOAD filename1.pdf 0000000000-23-007311 46838
2023-06-26 CORRESP filename1.htm 0001140361-23-031411 52928
2023-06-26 PRER14A PRER14A 0001140361-23-031407 000-51173 231042402 34 16051621
2023-06-20 DEFA14A DEFA14A 0001140361-23-030520 000-51173 231026108 34 69004
2023-06-20 8-K 8-K 3.03,5.03,9.01 0001140361-23-030517 000-51173 231026087 34 235199 1 1
2023-05-31 UPLOAD filename1.pdf 0000000000-23-005741 50196
2023-05-15 10-Q 10-Q 0001564590-23-007276 000-51173 23923260 34 6344059 1 1
2023-05-15 CORRESP filename1.htm 0001140361-23-024688 131336
2023-05-15 PRER14A PRER14A 0001140361-23-024684 000-51173 23921852 34 14759941
2023-05-05 DEFA14A DEFA14A 0001140361-23-023203 000-51173 23893813 34 26606
2023-05-05 8-K 8-K 3.01 0001140361-23-023200 000-51173 23893762 34 175598 1 1
2023-04-27 UPLOAD filename1.pdf 0000000000-23-004351 87964
2023-04-07 DEFA14A DEFA14A 0001140361-23-017339 000-51173 23808963 34 22515
2023-04-07 8-K FORM 8-K 3.01 0001140361-23-017337 000-51173 23808920 34 170435 1 1
2023-03-30 PREM14A PREM14A 0001140361-23-014858 000-51173 23781366 34 14087013
2023-03-30 DEFA14A DEFA14A 0001140361-23-014821 000-51173 23780829 34 208352
2023-03-30 8-K 8-K 1.01,9.01 0001140361-23-014819 000-51173 23780813 34 390155 1 1
2023-03-30 10-K 10-K 0001564590-23-004830 000-51173 23780565 34 9977497 1 1
2023-03-21 DEFA14A 8-K 0001140361-23-012661 000-51173 23747776 34 5509429
2023-03-21 8-K 8-K 7.01,9.01 0001140361-23-012659 000-51173 23747771 34 5655910 1 1
2023-03-02 DEFA14A DEFA14A 0001140361-23-009749 000-51173 23699192 34 401375
2023-03-02 8-K 8-K 1.01,2.01,8.01,9.01 0001140361-23-009748 000-51173 23699143 34 694969 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021833 005-82442 23630778 34 49191
2023-02-14 SC 13G/A AMENDMENT NO. 1 0000947871-23-000166 005-82442 23629199 34 58232
2023-02-13 SC 13G/A catalyst13ga1.htm 0000935836-23-000176 005-82442 23617427 34 30862
2023-02-13 SC 13G/A cbio-13g_20221231.txt 0001037389-23-000071 005-82442 23616024 34 13341
2023-01-19 8-K 8-K 5.02,9.01 0001140361-23-002126 000-51173 23537437 34 167317 1 1
2023-01-05 3 FORM 3 SUBMISSION 0000899243-23-000969 6886
2023-01-05 3 FORM 3 SUBMISSION 0000899243-23-000968 17917
2023-01-05 3 FORM 3 SUBMISSION 0000899243-23-000964 6889
2023-01-05 SC 13D SC 13D 0001193125-23-001641 005-82442 23508711 34 88174
2022-12-27 425 425 0001140361-22-046944 000-51173 221486791 34 3353113
2022-12-27 8-K 8-K 1.01,2.01,3.02,5.02,5.03,7.01,8.01,9.01 0001140361-22-046943 000-51173 221486788 34 3843863 1 1
2022-11-14 10-Q 10-Q 0001564590-22-037555 000-51173 221383047 34 6739207 1 1
2022-11-04 8-K 8-K 3.01 0001140361-22-040002 000-51173 221362241 34 163172 1 1
2022-10-07 SC 13D/A eps10473.htm 0001171520-22-000489 005-82442 221299301 34 143082
2022-09-22 SC 13D/A SC 13D/A 0001104659-22-102340 005-82442 221259396 34 69270
2022-08-25 8-K 8-K 8.01,9.01 0001140361-22-030838 000-51173 221193639 34 171433 1 1
2022-08-19 SC 13D/A eps10444_jds.htm 0001171520-22-000460 005-82442 221181222 34 230058
2022-08-19 8-K 8-K 8.01,9.01 0001140361-22-030333 000-51173 221179136 34 336005 1 1
2022-08-15 8-K 8-K 5.07 0001140361-22-029646 000-51173 221166325 34 171818 1 1
2022-08-15 8-K 8-K 2.02,9.01 0001140361-22-029645 000-51173 221166253 34 325974 1 1
2022-08-15 10-Q 10-Q 0001564590-22-029487 000-51173 221165598 34 6396645 1 1
2022-08-11 DFAN14A eps10420_jds.htm 0001171520-22-000456 000-51173 221153526 34 10526
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045256 6037
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045254 4790
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045251 4850
2022-08-10 DEFA14A DEFA 14A 0001140361-22-029023 000-51173 221151204 34 16155
2022-08-04 DEFA14A DEFA14A 0001140361-22-028188 000-51173 221136368 34 854963
2022-08-03 DFAN14A eps10404_jds.htm 0001171520-22-000451 000-51173 221132911 34 9575
2022-08-03 SC 13D/A eps10403_jds.htm 0001171520-22-000449 005-82442 221132862 34 202630
2022-08-03 DEFA14A FORM DEFA14A 0001140361-22-027931 000-51173 221130985 34 22328
2022-08-01 SC 13D/A SC 13D/A 0001104659-22-084700 005-82442 221124921 34 75295
2022-08-01 DEFA14A DEFA14A 0001140361-22-027567 000-51173 221122925 34 171990542
2022-08-01 8-K FORM 8-K 8.01,9.01 0001140361-22-027565 000-51173 221122914 34 276704 1 1
2022-08-01 DEFA14A DEFA14A 0001140361-22-027511 000-51173 221122083 34 45942134
2022-07-29 DEFA14A DEFA14A 0001140361-22-027478 000-51173 221121657 34 10584749
2022-07-28 DFAN14A eps10386_jds.htm 0001171520-22-000430 000-51173 221113023 34 168427
2022-07-22 SC 13D/A eps10375_jds.htm 0001171520-22-000426 005-82442 221099649 34 178617
2022-07-22 DFAN14A eps10374.htm 0001171520-22-000424 000-51173 221099639 34 17143
2022-07-22 DFAN14A eps10373_jds.htm 0001171520-22-000422 000-51173 221099629 34 33521
2022-07-21 DFAN14A eps10371_jds.htm 0001171520-22-000420 000-51173 221096710 34 29936
2022-07-19 DEFC14A DEFC14A 0001104659-22-080876 000-51173 221092958 34 1210853
2022-07-19 DEFC14A DEFC14A 0001140361-22-026309 000-51173 221090419 34 3716830
2022-07-19 DEFA14A FORM DEFA14A 0001140361-22-026308 000-51173 221090417 34 38413
2022-07-18 PRRN14A PRRN14A 0001104659-22-080547 000-51173 221089794 34 1203911
2022-07-18 UPLOAD filename1.pdf 0000000000-22-007534 44459
2022-07-14 PRRN14A PRRN14A 0001104659-22-079912 000-51173 221083636 34 1197619
2022-07-11 8-K FORM 8-K 7.01,9.01 0001140361-22-025671 000-51173 221076202 34 22141674 1 1
2022-07-08 PREC14A PREC14A 0001140361-22-025586 000-51173 221074296 34 3943001
2022-07-06 DEFA14A DEFA14A 0001193125-22-188320 000-51173 221067578 34 19377
2022-07-01 SC 13D/A SC 13D/A 0001104659-22-076841 005-82442 221061583 34 78000
2022-06-29 DEFA14A DEFA14A 0001193125-22-184509 000-51173 221052246 34 21149
2022-06-28 DEFA14A DEFA14A 0001193125-22-183026 000-51173 221045892 34 240267
2022-06-27 8-K 8-K 8.01,9.01 0001193125-22-181696 000-51173 221041153 34 409696 1 1
2022-06-21 SC 13D SC 13D 0001104659-22-073028 005-82442 221028871 34 107606
2022-06-17 DFAN14A eps10317.htm 0001171520-22-000372 000-51173 221024347 34 23491
2022-06-17 SC 13D/A eps10316.htm 0001171520-22-000371 005-82442 221024312 34 149822
2022-06-09 DEFA14A DEFA14A 0001193125-22-170395 000-51173 221004699 34 20656
2022-06-09 8-K 8-K 8.01 0001193125-22-170374 000-51173 221004648 34 148217 1 1
2022-05-25 DFAN14A eps10286.htm 0001171520-22-000346 000-51173 22963884 34 20061
2022-05-25 SC 13D/A eps10285.htm 0001171520-22-000347 005-82442 22963883 34 184227
2022-05-24 8-K/A 8-K/A 9.01 0001193125-22-157739 000-51173 22953687 34 238039 1 1
2022-05-23 8-K 8-K 1.01,2.01,9.01 0001193125-22-156879 000-51173 22949661 34 258856 1 1
2022-05-10 DFAN14A eps10232.htm 0001171520-22-000300 000-51173 22910811 34 25576
2022-05-10 SC 13D/A eps10231.htm 0001171520-22-000299 005-82442 22910743 34 149639
2022-05-09 PRRN14A eps10222.htm 0001171520-22-000290 000-51173 22906035 34 818136
2022-05-09 8-K 8-K 2.02,9.01 0001193125-22-144986 000-51173 22904995 34 221603 1 1
2022-05-09 10-Q 10-Q 0001564590-22-018775 000-51173 22904170 34 6207225 1 1
2022-05-04 UPLOAD filename1.pdf 0000000000-22-004863 45324
2022-05-02 DFAN14A eps10201.htm 0001171520-22-000272 000-51173 22883456 34 21738
2022-05-02 SC 13D/A eps10200.htm 0001171520-22-000271 005-82442 22883430 34 146940
2022-05-02 10-K/A FORM 10-K/A 0001193125-22-136435 000-51173 22881197 34 660710 1 1
2022-04-28 PREC14A eps10193.htm 0001171520-22-000258 000-51173 22868252 34 790340
2022-04-21 DFAN14A eps10185.htm 0001171520-22-000253 000-51173 22840805 34 16944
2022-04-21 SC 13D/A eps10184.htm 0001171520-22-000251 005-82442 22840798 34 143066
2022-04-05 8-K 8-K 2.02,2.05,5.02,9.01 0001193125-22-095321 000-51173 22804648 34 294262 1 1
2022-03-31 S-8 S-8 0001193125-22-091897 333-264027 22793316 33 70191
2022-03-31 10-K 10-K 0001564590-22-012877 000-51173 22790831 34 10474210 1 1
2022-03-16 DFAN14A eps10129.htm 0001171520-22-000196 000-51173 22743335 34 16623
2022-03-16 SC 13D/A eps10128.htm 0001171520-22-000194 005-82442 22743326 34 144008
2022-03-16 8-K 8-K 1.02,9.01 0001193125-22-076406 000-51173 22742810 34 162965 1 1
2022-03-07 DFAN14A eps10122.htm 0001171520-22-000187 000-51173 22717956 34 27603
2022-03-07 SC 13D/A eps10121.htm 0001171520-22-000185 005-82442 22717943 34 700972
2022-03-04 SC 13G catalystbiosciences13g.htm 0000935836-22-000227 005-82442 22715333 34 30123
2022-02-28 DFAN14A eps10115.htm 0001171520-22-000169 000-51173 22686943 34 18987
2022-02-28 SC 13D/A eps10114.htm 0001171520-22-000167 005-82442 22686761 34 131561
2022-02-23 4 FORM 4 SUBMISSION 0001209191-22-012159 5565
2022-02-23 4 FORM 4 SUBMISSION 0001209191-22-012156 5625
2022-02-23 DFAN14A eps10101.htm 0001171520-22-000148 000-51173 22660165 34 22088
2022-02-23 SC 13D/A eps10100.htm 0001171520-22-000147 005-82442 22660155 34 146868
2022-02-18 8-K 8-K 3.01 0001193125-22-046614 000-51173 22652953 34 145087 1 1
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010407 6038
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010403 4791
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010392 4851
2022-02-14 SC 13G/A catalyst13ga1.htm 0000935836-22-000176 005-82442 22633371 34 38021
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-021623 005-82442 22625399 34 46049
2022-02-14 SC 13G/A catalystbio13g2022.htm 0000935836-22-000109 005-82442 22623244 34 60925
2022-02-11 SC 13G SCHEDULE 13G 0000947871-22-000195 005-82442 22621231 34 65151
2022-02-11 SC 13G cbio-13g_20211231.txt 0001037389-22-000212 005-82442 22621181 34 13317
2022-01-27 SC 13D/A SC 13D/A 0001104659-22-008147 005-82442 22561835 34 141202
2022-01-25 8-K 8-K 8.01,9.01 0001193125-22-016551 000-51173 22551153 34 159860 1 1
2022-01-18 SC 13G Schedule13G.txt 0001546007-22-000003 005-82442 22533514 34 9255

Latest XBRL company facts

One latest value per concept from companyfacts (515 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 115.32M 2026-11-01 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
dei EntityPublicFloat Entity Public Float USD 72.60M 2025-06-30 2025 FY 10-K 2026-03-13 0001193125-26-106251
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.50M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017124
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.65M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017124
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 89 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017124
ffd NetFeeAmt NetFeeAmt USD 4,199.28 2026-08-27 S-8 2026-08-27 0001140361-26-034882
ffd TtlFeeAmt TtlFeeAmt USD 4,199.28 2026-08-27 S-8 2026-08-27 0001140361-26-034882
ffd TtlOfferingAmt TtlOfferingAmt USD 30.41M 2026-08-27 S-8 2026-08-27 0001140361-26-034882
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-27 S-8 2026-08-27 0001140361-26-034882
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 24,373.79 2026-07-13 S-3/A 2026-07-13 0001140361-26-028333
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 5.00M 2022-12-31 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap AccountsNotesAndLoansReceivableNetCurrent Accounts and Financing Receivable, after Allowance for Credit Loss, Current USD 33.46M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 17.04M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.64M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 33.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 32.66M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 708,000 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 2.83M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 17.04M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.30M 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 443,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 100,000 2026-06-30 2026 Q2 10-Q 2026-08-07 0001193125-26-340448
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 13.58M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 2.73M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 243.49M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 774,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.73M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 3.56M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 3.41M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap AdvertisingExpense Advertising Expense USD 11.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 200,000 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 2,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0000950170-25-068089
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 39,000 2015-01-01 2015-06-30 8-K/A 2015-10-23 0001193125-15-351944
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 51.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 89,000 2014-01-01 2014-06-30 2014 Q3 10-Q 2014-11-06 0001193125-14-400415
us-gaap Assets Assets USD 201.25M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AssetsCurrent Assets, Current USD 123.40M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 21.99M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap AssetsHeldForSaleCurrent Assets Held-for-sale, Current (Deprecated 2014-01-31) USD 317,000 2013-09-30 2013 Q3 10-Q 2013-11-06 0001193125-13-429542
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 28,000 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap AssetsNoncurrent Assets, Noncurrent USD 910,981 2014-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 1.53M 2012-12-31 2013 Q3 10-Q 2013-11-06 0001193125-13-429542
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 67.18M 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272383
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 64.53M 2021-09-30 2021 Q3 10-Q 2021-11-12 0001564590-21-056450
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2021-09-30 2021 Q3 10-Q 2021-11-12 0001564590-21-056450
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 6,000 2018-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 64.53M 2021-09-30 2021 Q3 10-Q 2021-11-12 0001564590-21-056450
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 12.63M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 2.50M 2020-12-31 2020 FY 10-K 2021-03-04 0001564590-21-010823
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 105.20M 2013-03-31 2013 Q1 10-Q 2013-05-08 0001193125-13-207383
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001564590-21-056450
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 298,000 2013-03-31 2013 Q1 10-Q 2013-05-08 0001193125-13-207383
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 9,000 2013-03-31 2013 Q1 10-Q 2013-05-08 0001193125-13-207383
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 183,000 2015-08-20 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables USD 318,000 2015-08-20 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles USD 700,000 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 73.69M 2015-08-20 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap Cash Cash USD 33.50M 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037242
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 5.59M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 41.64M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 4.21M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-19 0001564590-18-006216
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 33.50M 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037242
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 126.72M 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010740
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 41.64M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -7.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 17.90M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 52.32M 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap ChangeInReportingEntityEarningsPerShareBasic ChangeInReportingEntityEarningsPerShareBasic USD/shares -0.05 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001193125-26-340448
us-gaap ChangeInReportingEntityEarningsPerShareDiluted ChangeInReportingEntityEarningsPerShareDiluted USD/shares -0.05 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001193125-26-340448
us-gaap ChangeInReportingEntityIncomeLossAfterTaxAttributableToParent ChangeInReportingEntityIncomeLossAfterTaxAttributableToParent USD -8.72M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001193125-26-340448
us-gaap ChangeInReportingEntityOtherComprehensiveIncomeLossAfterTax ChangeInReportingEntityOtherComprehensiveIncomeLossAfterTax USD -163,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001193125-26-340448
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 4,915 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 2.07M 2017-04-12 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 85 2020-12-31 2020 FY 10-K 2021-03-04 0001564590-21-010823
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 41.71M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0.24 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0.24 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 107.07M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 107.07M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap CommonStockValue Common Stock, Value, Issued USD 107,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -24.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -8.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -7.90M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure USD 21.40M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap ContractsRevenue Contracts Revenue (Deprecated 2018-01-31) USD 6,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010740
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 0 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 14,000 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 460,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 241,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2018-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 5.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 691,000 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-06 0001193125-12-099259
us-gaap CostsAndExpenses Costs and Expenses USD 121.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 207,000 2017-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 348,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 341,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 5.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 5.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 2,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 3,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss USD 77.28M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance shares 3.88M 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -91,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037242
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -1.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 10.13M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -1.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 0 2014-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap DeferredRentCredit Deferred Rent Credit USD 26,314 2014-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 15,000 2018-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 174,000 2018-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap DeferredRevenue Deferred Revenue USD 4.86M 2012-06-30 2012 Q2 10-Q 2012-08-09 0001193125-12-347071
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 36,000 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126306
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 1.55M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 200,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -1.49M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 39,000 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037242
us-gaap DeferredTaxAssetsEquityMethodInvestments Deferred Tax Assets, Equity Method Investments USD 150,000 2022-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037242
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 77.41M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2014-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 6.87M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 42.24M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 26,000 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 4.46M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 4.46M 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 3.92M 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 7.32M 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 1.59M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 70.15M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 9.60M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 211,000 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 194,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) pure 0.04 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-15 0001193125-13-109464
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.04 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap DepositLiabilityCurrent Deposit Liability, Current USD 730,000 2016-06-30 2016 Q2 10-Q 2016-08-04 0001564590-16-022517
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 133,000 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 128,000 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010740
us-gaap Depreciation Depreciation USD 2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 1.06M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-19 0001564590-18-006216
us-gaap DerivativeLiabilities Derivative Liability USD 0 2017-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1.16M 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 3.06M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 206,000 2023-01-01 2023-03-31 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap DividendsCommonStockStock Dividends, Common Stock, Stock USD 7.56M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 7.56M 2022-12-31 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.46 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0001564590-22-018775
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.033 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.031 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends Effective Income Tax Rate Reconciliation, Deduction, Employee Stock Ownership Plan Dividend, Percent pure 0.011 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.039 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.066 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.034 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.01 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.03 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-15 0001193125-13-109464
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.421 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.02 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 1.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) USD 7.54M 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-08 0001193125-13-207383
us-gaap EquityMethodInvestmentOtherThanTemporaryImpairment Equity Method Investment, Other than Temporary Impairment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap EquityMethodInvestments Equity Method Investments USD 1.80M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 3.41M 2014-01-01 2014-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 3.50M 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-15 0001193125-13-109464
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 95,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) USD -91,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Transfers, Net (Deprecated 2019-01-31) USD -774,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 474,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 391,000 2014-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 1.97M 2015-06-30 8-K/A 2015-10-23 0001193125-15-351944
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) USD -1.06M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings USD -99,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues USD 1.46M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements USD 5,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs USD 1.16M 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 1.61M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 1.38M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 723,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 182,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 648,000 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 680,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 691,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 692,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 6.02M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 4.40M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 100,000 2009-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap ForeignCurrencyTransactionGainLossAfterTax ForeignCurrencyTransactionGainLossAfterTax USD -165,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -116,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -4,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD -2.71M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD 13,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-19 0001564590-18-006216
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 26.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap GrossProfit Gross Profit USD 75.72M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272383
us-gaap HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 28.77M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 28.77M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost USD 44.55M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Fair Value USD 44.55M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 15.77M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 15.77M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 77.35M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 53,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -5.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -34.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 19.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -11.07M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -35.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 4.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2024-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 7.30M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-19 0001564590-18-006216
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 7.30M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-19 0001564590-18-006216
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 3.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD -1.62M 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -1.27M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 403,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -2.41M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -456,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -230,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -9.27M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 128,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 4.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable USD -234,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 1.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncreaseDecreaseInNotesReceivables Increase (Decrease) in Notes Receivables USD -4.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -47,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -406,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 96,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -2.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IncreaseDecreaseInPrepaidInsurance Increase (Decrease) in Prepaid Insurance USD 33,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap IncreaseDecreaseInPrepaidRent Increase (Decrease) in Prepaid Rent USD -182,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -123,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 57,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-19 0001564590-18-006216
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 13.11M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 54,102 2013-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap InterestAndOtherIncome Interest and Other Income USD 165,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0001564590-22-018775
us-gaap InterestExpense Interest Expense USD 1.48M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 2.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 537,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 26,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap InterestReceivable Interest Receivable USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 2.75M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap InventoryGross Inventory, Gross USD 11.35M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap InventoryNet Inventory, Net USD 12.22M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 1.98M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 0 2025-06-30 2025 Q2 10-Q 2025-08-11 0000950170-25-106644
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 7.48M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 160,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap InvestmentIncomeDividend Investment Income, Dividend USD 4,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 224,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-08 0001193125-13-207383
us-gaap InvestmentIncomeNet Investment Income, Net USD 153,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap LegalFees Legal Fees USD 600,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.83M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.15M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 209 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041706
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 198,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 224,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 694,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 365,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 825,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap Liabilities Liabilities USD 35.18M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 201.25M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap LiabilitiesCurrent Liabilities, Current USD 28.59M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 2.87M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 1.12M 2014-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 3.54M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 16.35M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-06 0001193125-12-099259
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 0 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap LongTermDebt Long-term Debt USD 0 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 853,000 2013-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 853,000 2013-12-31 2013 FY 10-K 2014-03-14 0001193125-14-099974
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 283,000 2012-12-31 2012 FY 10-K 2013-03-15 0001193125-13-109464
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 283,000 2013-12-31 2013 FY 10-K 2014-03-14 0001193125-14-099974
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 851,000 2012-12-31 2012 FY 10-K 2013-03-15 0001193125-13-109464
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 283,000 2013-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap LongTermInvestments Long-term Investments USD 1.59M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 21.58M 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 828,000 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 36.56M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 234,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 111.22M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010740
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 8.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 803,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010740
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -17.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -5.11M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010740
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -35.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -10.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -28.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -28.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 153,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap NotesAndLoansReceivableGrossCurrent Financing Receivable, before Allowance for Credit Loss, Current USD 793,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 793,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 1.46M 2015-06-30 8-K/A 2015-10-23 0001193125-15-351944
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OperatingExpenses Operating Expenses USD 121.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -34.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 3.01M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.14M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.30M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.59M 2018-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 571,000 2018-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals USD 341,682 2014-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 209,000 2018-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 617,000 2018-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 605,000 2018-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 587,000 2018-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 122,000 2018-09-30 2018 Q3 10-Q 2018-11-01 0001564590-18-026288
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 400,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.076 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 588,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherAssetsCurrent Other Assets, Current USD 1.49M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 852,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 6.79M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest USD -5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -79,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest USD 1.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 5.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax USD -12,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 6,000 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-04 0001564590-16-022517
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax USD -7,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001193125-14-099974
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 1.41M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2013-01-31) USD -12,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-08 0001193125-13-207383
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax USD -19,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 21,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -5,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 11,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001193125-26-340448
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 4.93M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 119,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 315,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058642
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 109,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058642
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -1.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 32,000 2013-09-30 2013 Q3 10-Q 2013-11-06 0001193125-13-429542
us-gaap OtherTaxExpenseBenefit Other Tax Expense (Benefit) USD 72,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 1.48M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD -36.94M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-07 0001193125-13-324131
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 82,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap PaymentsOfDividends Payments of Dividends USD 12.76M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap PaymentsOfDividendsCommonStock Payments of Ordinary Dividends, Common Stock USD 7.60M 2023-01-12 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 1.49M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 1.69M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 1.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 839,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012877
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap PaymentsToAcquireRestrictedCertificatesOfDeposit Payments to Acquire Restricted Certificates of Deposit USD 18.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 564,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 3.95M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037242
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037242
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037555
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037555
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 33.31M 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 7.42M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 379,000 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 741,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap PrepaidInsurance Prepaid Insurance USD 1.17M 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap PrepaidTaxes Prepaid Taxes USD 766,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 1.89M 2015-01-01 2015-06-30 8-K/A 2015-10-23 0001193125-15-351944
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 23.00M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 7.26M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 2.13M 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-14 0001193125-14-099974
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 5.00M 2017-04-11 2017-04-12 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 2.50M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 1.89M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap ProceedsFromRepaymentsOfRestrictedCashFinancingActivities Proceeds from (Repayments of) Restricted Cash, Financing Activities USD 14.32M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-19 0001564590-18-006216
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 31.63M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap ProceedsFromSaleAndMaturityOfOtherInvestments Proceeds from Sale and Maturity of Other Investments USD 14.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 2.50M 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 10.00M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 17.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 1.00M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 61,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 447,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 442,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 9.54M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -35.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 40.59M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 27.01M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap PropertyPlantAndEquipmentOther Property, Plant and Equipment, Other, Gross USD 3.38M 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460294
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 200,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 10,000 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD -11,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap RecognitionOfDeferredRevenue Recognition of Deferred Revenue USD 123,000 2014-01-01 2014-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 5.08M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 437,000 2014-01-01 2014-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 1.68M 2008-03-01 2008-03-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 24.24M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 6.74M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 35.39M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 12.73M 2017-03-31 2017 Q1 10-Q 2017-05-11 0001564590-17-010578
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 125,000 2017-03-31 2017 Q1 10-Q 2017-05-11 0001564590-17-010578
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2020-06-30 2020 Q2 10-Q 2020-08-06 0001564590-20-037483
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 125,000 2016-12-31 2017 FY 10-K 2018-03-19 0001564590-18-006216
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employee 22 2022-03-01 2022-03-31 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.35 2021-11-01 2021-11-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap RestructuringCharges Restructuring Charges USD 1.01M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -142.01M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 86.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 105.76M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 275,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap Revenues Revenues USD 60,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 587,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 473,000 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-06 0001193125-12-099259
us-gaap SecurityDeposit Security Deposit USD 500,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap SegmentExpenditureAdditionToLongLivedAssets SegmentExpenditureAdditionToLongLivedAssets USD 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 42.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 26.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap SeveranceCosts Severance Costs (Deprecated 2013-01-31) USD 306,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-08 0001193125-13-207383
us-gaap SeveranceCosts1 Severance Costs USD 400,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 698,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-31 0001193125-15-272118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 333,082 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001193125-14-099974
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 4.92 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001193125-14-099974
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 926,650 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001193125-14-099974
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.38 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001193125-14-099974
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 1.58M 2019-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 4.04 2013-12-31 2013 FY 10-K 2014-03-14 0001193125-14-099974
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 803,484 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001193125-14-099974
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 5.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 6.45 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001193125-14-099974
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.843 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 2.10M 2025-11-20 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 25.52M 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 88.55M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 16.17M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 1.95 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 17.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 10,945 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 14.21M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 0.91 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 28,170 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 210,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 5.98 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 1.05M 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 526,475 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 3.82 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 3.5 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 88.59M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 19.64M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.14 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 1,000 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 1.57M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041706
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 10.99 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041706
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 84,378 2014-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 748,782 2014-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 0.34 2014-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.90M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 0 2023-01-01 2023-03-31 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 4.75 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 573,000 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-06 0001193125-13-429542
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.89 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 117.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 11.7 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 7.31 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 7.57 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 0.05 2014-01-01 2014-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 0.4 2014-01-01 2014-12-31 8-K/A 2015-10-23 0001193125-15-351944
us-gaap SharePrice Share Price USD/shares 5.28 2017-04-12 2018 FY 10-K 2019-03-08 0001564590-19-006879
us-gaap ShortTermInvestments Short-term Investments USD 15.77M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 57,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 107.95M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 144.52M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) USD 30.98M 2017-12-31 2019 FY 10-K 2020-02-20 0001564590-20-005546
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-26 0000950170-23-055695
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 23,114 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214676
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 21.25M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 879,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 23.00M 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 233,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 7.50M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 108.88M 2014-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2015-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2015-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2015-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2015-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2015-12-31 2015 FY 10-K 2016-03-09 0001193125-16-498295
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 82,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001193125-15-368527
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.88M 2025-12-31 2025 FY 10-K 2026-03-13 0001193125-26-106251
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD -6,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003722
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition Unrecognized Tax Benefits, Increase Resulting from Acquisition USD 1.88M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040279
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD -159,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 15.03M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093871
us-gaap ValuationAllowancesAndReservesPeriodIncreaseDecrease SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) USD -5.50M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001564590-23-004830
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 261,401 2012-01-01 2012-09-30 2013 Q3 10-Q 2013-11-06 0001193125-13-429542
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 99.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 31.46M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0001564590-22-018775
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 99.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 99.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450334

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →